European Union:
The Deloitte Alternative Lender Deal Tracker Q1 2016 - Brexit: Opportunity Or Threat?
To print this article, all you need is to be registered or login on Mondaq.com.
The Deloitte Alternative Lender Deal Tracker covers 46 leading
Alternative Lenders, with whom we track primary mid-market deals
across Europe.
This eleventh issue covers data for the first quarter of 2016
that closed with 63 deals completing, representing an 8% increase
in deal flow in comparison with the previous year
(Year-on-Year).
Key highlights
- The number of deals covered has
increased to 713 transactions over the
past 14 quarters
- This issue covers data for the
first quarter of 2016 that closed with 63 deals
completing, representing an impressive 8% increase in deal
flow in comparison with the previous year (Year-on-Year)
- In the last 12 months, 29% of
the alternative lending transactions were completed with
family and founder owned businesses without a
majority private equity sponsor
Deloitte Alternative Lender Deal Tracker
Download the full report
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Finance and Banking from European Union
Asset Recovery Comparative Guide
Bird & Bird
Asset Recovery Comparative Guide for the jurisdiction of UK, check out our comparative guides section to compare across multiple countries
FCA's Consultation Paper
Cadwalader, Wickersham & Taft LLP
Since 3 January 2018, firms that provide portfolio management or investment advice on an independent basis must pay for the research they obtain...
Regulation Round Up
Proskauer Rose LLP
Welcome to the UK Regulation Round Up, a regular bulletin highlighting the latest developments in UK and EU financial services regulation.
FCA To Permit Research Bundling
Akin Gump Strauss Hauer & Feld LLP
The Financial Conduct Authority (FCA) is seeking views on proposed rules that would allow asset managers to opt for bundled payments for third-party investment research, reversing a significant aspect of the UK's implementation of research rules under the Markets in Financial Instruments Directive (MiFID II).